Logo

University of Michigan Wins $6M NIAID Grant to Help Develop Anthrax Vaccine

Dec 02, 2004

NEW YORK, Dec. 2 (GenomeWeb News) - The University of Michigan Medical School has won a $5.9 million grant from the National Institute of Allergy and Infectious Diseases to apply its proteomics research to help develop a widely used anthrax vaccine, the school said today.

 

Michiganwas chosen as one of seven government-funded Biodefense Proteomics Research Centers. Philip Hanna is co-director of the center and assistant professor of microbiology and immunology at the university.

Breaking News
The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.